advertisement

---

Patel V 15

Showing records 1 to 15 | Display all abstracts from Patel V

113384 Novel Methods of Identifying Individual and Neighborhood Risk Factors for Loss to Follow-Up After Ophthalmic Screening
Heilenbach N
Journal of Glaucoma 2023; 0:

---

113081 Preclinical Evaluation of a Novel Once-a-Day Brimonidine Ophthalmic Nanosuspension
Khopade AJ
Journal of Ocular Pharmacology and Therapeutics 2023; 0:

---

113384 Novel Methods of Identifying Individual and Neighborhood Risk Factors for Loss to Follow-Up After Ophthalmic Screening
Ogunsola T
Journal of Glaucoma 2023; 0:

---

113081 Preclinical Evaluation of a Novel Once-a-Day Brimonidine Ophthalmic Nanosuspension
Halder A; Patel V
Journal of Ocular Pharmacology and Therapeutics 2023; 0:

---

113384 Novel Methods of Identifying Individual and Neighborhood Risk Factors for Loss to Follow-Up After Ophthalmic Screening
Elgin C; Fry D
Journal of Glaucoma 2023; 0:

---

113081 Preclinical Evaluation of a Novel Once-a-Day Brimonidine Ophthalmic Nanosuspension
Upadhyay S; Burade V
Journal of Ocular Pharmacology and Therapeutics 2023; 0:

---

113384 Novel Methods of Identifying Individual and Neighborhood Risk Factors for Loss to Follow-Up After Ophthalmic Screening
Iskander M
Journal of Glaucoma 2023; 0:

---

113081 Preclinical Evaluation of a Novel Once-a-Day Brimonidine Ophthalmic Nanosuspension
Pateliya B
Journal of Ocular Pharmacology and Therapeutics 2023; 0:

---

113384 Novel Methods of Identifying Individual and Neighborhood Risk Factors for Loss to Follow-Up After Ophthalmic Screening
Abazah Y; Aboseria A
Journal of Glaucoma 2023; 0:

---

113081 Preclinical Evaluation of a Novel Once-a-Day Brimonidine Ophthalmic Nanosuspension
Panchal S
Journal of Ocular Pharmacology and Therapeutics 2023; 0:

---

113384 Novel Methods of Identifying Individual and Neighborhood Risk Factors for Loss to Follow-Up After Ophthalmic Screening
Alshamah R
Journal of Glaucoma 2023; 0:

---

113081 Preclinical Evaluation of a Novel Once-a-Day Brimonidine Ophthalmic Nanosuspension
Mandhane S
Journal of Ocular Pharmacology and Therapeutics 2023; 0:

---

113384 Novel Methods of Identifying Individual and Neighborhood Risk Factors for Loss to Follow-Up After Ophthalmic Screening
Alshamah J
Journal of Glaucoma 2023; 0:

---

113081 Preclinical Evaluation of a Novel Once-a-Day Brimonidine Ophthalmic Nanosuspension
Awati C; Zope M
Journal of Ocular Pharmacology and Therapeutics 2023; 0:

---

113384 Novel Methods of Identifying Individual and Neighborhood Risk Factors for Loss to Follow-Up After Ophthalmic Screening
Mooney SJ; Maestre G; Lovasi GS; Patel V; Al-Aswad LA
Journal of Glaucoma 2023; 0:

---